Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans.

Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T.

J Biochem. 1999 Apr;125(4):803-8.

2.
3.

Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population.

Chida M, Yokoi T, Fukui T, Kinoshita M, Yokota J, Kamataki T.

Jpn J Cancer Res. 1999 Sep;90(9):899-902.

PMID:
10551315
4.

Effect of a genetic polymorphism of CYP1A2 inducibility on the steady state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia.

Mihara K, Suzuki A, Kondo T, Yasui N, Furukori H, Nagashima U, Ono S, Kaneko S, Otani K, Inoue Y.

Ther Drug Monit. 2000 Jun;22(3):245-9.

PMID:
10850389
6.

Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene.

Nakajima M, Yokoi T, Mizutani M, Shin S, Kadlubar FF, Kamataki T.

Cancer Epidemiol Biomarkers Prev. 1994 Jul-Aug;3(5):413-21.

7.

G-2964A and C734A genetic polymorphisms of CYP1A2 in Chinese population.

Han XM, Chen XP, Wu QN, Jiang CH, Zhou HH.

Acta Pharmacol Sin. 2000 Nov;21(11):1031-4.

8.

Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.

Aklillu E, Carrillo JA, Makonnen E, Hellman K, Pitarque M, Bertilsson L, Ingelman-Sundberg M.

Mol Pharmacol. 2003 Sep;64(3):659-69.

9.
10.

Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine.

Sachse C, Brockmöller J, Bauer S, Roots I.

Br J Clin Pharmacol. 1999 Apr;47(4):445-9.

11.

The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.

Chen X, Wang L, Zhi L, Zhou G, Wang H, Zhang X, Hao B, Zhu Y, Cheng Z, He F.

Clin Pharmacol Ther. 2005 Sep;78(3):249-59.

PMID:
16153396
12.

The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.

Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, Domchek S, Randall S, Karlan B, Zhang P, Zhang S, Sun P, Narod SA.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):912-6.

13.

Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.

Ghotbi R, Christensen M, Roh HK, Ingelman-Sundberg M, Aklillu E, Bertilsson L.

Eur J Clin Pharmacol. 2007 Jun;63(6):537-46.

PMID:
17370067
14.

Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma.

Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY, Mitsuta-Izaki K, Matsuse H, Kinoshita M, Kohno S.

Clin Pharmacol Ther. 2003 May;73(5):468-74.

PMID:
12732846
15.

Genotype and allele frequencies of polymorphic cytochromes P450 CYP1A2 and CYP2E1 in Mexicans.

Mendoza-Cantú A, Castorena-Torres F, Bermudez M, Martínez-Hernández R, Ortega A, Salinas JE, Albores A.

Cell Biochem Funct. 2004 Jan-Feb;22(1):29-34.

PMID:
14695651
16.

Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.

Fu Y, Fan CH, Deng HH, Hu SH, Lv DP, Li LH, Wang JJ, Lu XQ.

Acta Pharmacol Sin. 2006 Mar;27(3):328-32.

17.

Polymorphic drug metabolism: studies with recombinant Chinese hamster cells and analyses in human populations.

Yokoi T, Sawada M, Kamataki T.

Pharmacogenetics. 1995;5 Spec No:S65-9.

PMID:
7581492
18.

Identification of non-functional allelic variant of CYP1A2 in dogs.

Mise M, Hashizume T, Matsumoto S, Terauchi Y, Fujii T.

Pharmacogenetics. 2004 Nov;14(11):769-73.

PMID:
15564884
19.

CYP1A2 polymorphism (C > A at position -163) in Ovambos, Koreans and Mongolians.

Fujihara J, Shiwaku K, Xue Y, Kataoka K, Hieda Y, Takeshita H.

Cell Biochem Funct. 2007 Sep-Oct;25(5):491-4.

PMID:
16933202
20.

Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population.

Soyama A, Saito Y, Hanioka N, Maekawa K, Komamura K, Kamakura S, Kitakaze M, Tomoike H, Ueno K, Goto Y, Kimura H, Katoh M, Sugai K, Saitoh O, Kawai M, Ohnuma T, Ohtsuki T, Suzuki C, Minami N, Kamatani N, Ozawa S, Sawada J.

Drug Metab Pharmacokinet. 2005 Feb;20(1):24-33. Erratum in: Drug Metab Pharmacokinet. 2005 Apr;20(2):152.

Items per page

Supplemental Content

Support Center